Johnson, Emma C. http://orcid.org/0000-0003-0394-777X
Austin-Zimmerman, Isabelle
Thorpe, Hayley H. A.
Levey, Daniel F.
Baranger, David A. A. http://orcid.org/0000-0002-6659-357X
Colbert, Sarah M. C. http://orcid.org/0000-0003-3060-7471
Demontis, Ditte http://orcid.org/0000-0001-9124-2766
Khokhar, Jibran Y. http://orcid.org/0000-0002-2169-2275
Davis, Lea K. http://orcid.org/0000-0001-5143-2282
Edenberg, Howard J. http://orcid.org/0000-0003-0344-9690
Di Forti, Marta
Sanchez-Roige, Sandra
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Agrawal, Arpana http://orcid.org/0000-0002-0313-793X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K01DA051759, R01DA058862)
Gouvernement du Canada | Canadian Institutes of Health Research (Postdoctoral Fellowship, Canada Research Chair in Translational Neuropsychopharmacology)
U.S. Department of Veterans Affairs (1IK2BX005058-01A2)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (K99AA030808)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 13 February 2024
Revised: 22 April 2024
Accepted: 6 May 2024
First Online: 21 June 2024
Competing interests
: JG is a holder of US patent 10,900,082 titled: ‘Genotype-guided dosing of opioid agonists’, issued 26 January 2021. JG is paid for their editorial work on the journal Complex Psychiatry. HHAT is on the <i>Neuropsychopharmacology</i> Special Projects Team. The remaining authors have nothing to disclose.